Accessibility Menu
Arrow-Thin-Down
S&P 500
6,734.11
-0.1%
-3.38
Arrow-Thin-Down
DJI
47,147.48
-0.7%
-309.74
Arrow-Thin-Down
NASDAQ
22,900.59
+0.1%
+30.23
Arrow-Thin-Down
Bitcoin
$96,255.00
+0.2%
+$216.44
Arrow-Thin-Down
AAPL
$272.17
-0.3%
-$0.78
Arrow-Thin-Down
AMZN
$234.57
-1.3%
-$3.02
Arrow-Thin-Down
GOOG
$276.69
-0.9%
-$2.43
Arrow-Thin-Down
META
$609.32
-0.1%
-$0.57
Arrow-Thin-Down
MSFT
$510.18
+1.4%
+$6.89
Arrow-Thin-Down
NVDA
$190.00
+1.7%
+$3.14
Arrow-Thin-Down
TSLA
$404.30
+0.6%
+$2.31
Daily Stock GainersDaily Stock LosersMost Active Stocks
Biomea Fusion Stock Quote

Biomea Fusion (NASDAQ: BMEA)

$1.28
(-0.8%)
-0.01
Price as of November 14, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$1.28
Daily Change
(-0.8%) $0.01
Day's Range
$1.26 - $1.32
Previous Close
$1.28
Open
$1.27
Beta
0
Volume
698,707
Average Volume
1,682,312
Sector
Health Care
Market Cap
90.5M
Market Cap / Employee
$1.28M
52wk Range
$1.22 - $7.50
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$2.39
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Biomea Fusion Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BMEA-82%N/AN/A-93%
S&P+13.19%+87.83%+13.42%+61%

Biomea Fusion Company Info

Biomea Fusion, Inc. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in Redwood City, CA.

News & Analysis

Featured Article

Biomea Fusion (BMEA) Q2 Loss Drops 44%

Motley Fool Markets Team  |  Aug 5, 2025
Featured Article

Why Biomea Fusion Stock Crushed It This Week

A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.

George Budwell  |  Mar 30, 2023

Financial Health

General

Q3 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$0.40M0.0%
Market Cap$120.21M-67.1%
Market Cap / Employee$2.86M-13.9%
Employees42-60.7%
Net Income-$16.41M50.0%
EBITDA-$18.20M45.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$46.64M-47.0%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$6.09M-11.4%
Short Term Debt$0.79M-70.8%

Ratios

Q3 2025YOY Change
Return On Assets-115.59%-29.7%
Return On Invested Capital-81.95%-1188.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$12.18M52.1%
Operating Free Cash Flow-$12.18M51.7%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book1.851.482.354.2721.40%
Price to Tangible Book Value1.851.482.354.2721.40%
Enterprise Value to EBITDA-3.08-1.71-1.15-4.46-47.83%
Return on Equity-125.4%-156.8%-170.5%-209.0%99.98%
Total Debt$8.77M$7.93M$7.05M$6.88M-28.13%

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services